Kisspeptin is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Single Kisspeptin-54 injection induces egg maturation in women undergoing IVF with successful fertilization and pregnancy. Intranasal Kisspeptin-54 robustly stimulates gonadotropins — the first non-invasive GnRH stimulation method. Early clinical success in IVF protocols. Kisspeptin is not fda-approved. investigational use only.
What Does the Research Say About Kisspeptin?
Single Kisspeptin-54 injection induces egg maturation in women undergoing IVF with successful fertilization and pregnancy. Intranasal Kisspeptin-54 robustly stimulates gonadotropins — the first non-invasive GnRH stimulation method. Early clinical success in IVF protocols.
Kisspeptin (Kisspeptin-10/Kisspeptin-54) is a Neuroendocrine peptide, GPR54 receptor agonist. Research interest has focused on its potential effects on reproductive hormone stimulation, fertility enhancement, egg maturation induction, ovulation triggering, testicular function support.
What Is the Evidence for Kisspeptin's Mechanism?
Binds GPR54 (KISS1R) on GnRH neurons in the hypothalamus, triggering GnRH neuronal firing and pulsatile GnRH secretion. This stimulates pituitary gonadotrophs to release LH and FSH, activating the entire reproductive hormone cascade from a single upstream signal.
These pathways have been identified through in vitro studies, animal models, and where available, human trials.
Are There Human Clinical Trials for Kisspeptin?
Single Kisspeptin-54 injection induces egg maturation in women undergoing IVF with successful fertilization and pregnancy. Intranasal Kisspeptin-54 robustly stimulates gonadotropins — the first non-invasive GnRH stimulation method. Early clinical success in IVF protocols.
The gap between preclinical promise and clinical validation remains the biggest challenge in peptide research. However, Kisspeptin has shown encouraging results.
What Does the Safety Research Show?
Minimal in early human studies. Potential headaches, flushing, or autonomic symptoms. Theoretical concerns for hormonal imbalance with chronic use.
Kisspeptin is not fda-approved. investigational use only.
What Makes Kisspeptin Unique in Research?
The gateway neuropeptide controlling the entire reproductive axis — the first peptide to achieve clinical success inducing egg maturation without exogenous hormones, representing a more physiological approach to fertility than hormone injection.
This differentiator is important because it means Kisspeptin fills a role that other compounds in its class may not fully replicate.
Bottom Line on Kisspeptin Research
The evidence base for Kisspeptin is growing. Key research areas include reproductive hormone stimulation, fertility enhancement, egg maturation induction, ovulation triggering, testicular function support.
Stay current with PubMed searches for Kisspeptin for the latest publications.
Complete Guide
Kisspeptin : Benefits, Dosage, Side Effects & Research
Related Reading
- Kisspeptin Dosage Guide
- Kisspeptin Benefits
- Kisspeptin Side Effects
- Kisspeptin Stacking Guide
- Kisspeptin Cycle Guide
- AOD-9604 Complete Guide
Calculate Your Kisspeptin Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Kisspeptin.
Open Calculator →Research-Grade Sourcing
If you're going to research Kisspeptin, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Kisspeptin?
Kisspeptin (Kisspeptin-10/Kisspeptin-54) is a Neuroendocrine peptide, GPR54 receptor agonist. Endogenous neuropeptide encoded by KISS1 gene; master regulator of the reproductive hormone axis. It is researched for reproductive hormone stimulation, fertility enhancement, egg maturation induction, ovulation triggering, testicular function support.
What is the recommended Kisspeptin dosage?
Common dosages: 100-200 mcg subcutaneous administered daily or pulsatile dosing via subcutaneous injection, intranasal (experimental). Cycle length: single dosing for IVF protocols; multi-week protocols undefined. Half-life: very short for Kisspeptin-10; longer for Kisspeptin-54. Use our peptide calculator for exact reconstitution math.
What are the side effects of Kisspeptin?
Minimal in early human studies. Potential headaches, flushing, or autonomic symptoms. Theoretical concerns for hormonal imbalance with chronic use.
Is Kisspeptin safe?
Kisspeptin has shown a preliminary safety profile in research. Not FDA-approved. Investigational use only. All research should follow appropriate safety protocols.